Medicared For All Logo

Venkat Pavan Kancharla in Melbourne, Florida

Home Florida Melbourne

Venkat Pavan Kancharla has Medical Oncology as his primary medical specialty. Their primary office is: 1430 S Pine St in Melbourne, Florida.

They're a part of the: Cancer Care Centers Of Brevard Inc medical group which has around 18 members. You can call their office at 321-952-0898 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1998 (around 26 years of experience). They are listed as doing telehealth appointments.

Venkat Pavan R Kancharla Office Phone and Directions

Venkat Pavan Kancharla
Cancer Care Centers Of Brevard Inc
1430 S Pine St
Melbourne, Florida 32901
321-952-0898

Patient Ratings
Please rate your experience with Venkat Pavan Kancharla below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 321-952-0898


Enter a starting address:


Healthcare Info for Venkat Pavan Kancharla

Medical School: Sorry, his university is not listed
Graduation Year: 1998
The Primary Medical Specialty for Venkat Pavan Kancharla is listed as: Medical Oncology
Approximate Years of Experience: 26
PAC (PECOS ID)#: 5799852398
NPI #: 1205091758
NPI Created On: 07/24/2008
NPI Last Updated Listed as: 01/07/2019
Primary Taxonomy Code: 207RX0202X
License Number:
ME112590
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • Florida Health Care Plans
  • Celtic Insurance Company
  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Hindi.

Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Complete blood cell count (red cells, white blood cell, platelets), automated test
  3. Hydration infusion into a vein 31 minutes to 1 hour
  4. Hydration infusion into a vein
  5. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  6. Infusion into a vein for therapy, prevention, or diagnosis
  7. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  8. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  9. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  10. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  11. Infusion of chemotherapy into a vein up to 1 hour
  12. Infusion of chemotherapy into a vein
  13. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  14. Irrigation of implanted venous access drug delivery device
  15. Therapeutic removal of whole blood to correct blood level imbalance
  16. New patient office or other outpatient visit, typically 30 minutes
  17. New patient office or other outpatient visit, typically 45 minutes
  18. Established patient office or other outpatient visit, typically 10 minutes
  19. Established patient office or other outpatient visit, typically 15 minutes
  20. Established patient office or other outpatient, visit typically 25 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787982937

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $120

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787982939

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $31

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787982941

Being Disputed:: No

Product Related: No

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787982949

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787982943

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787982945

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787982947

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787982951

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787982953

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787982955

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Medical Oncology Professionals in Melbourne

1.
David Ross MD

1430 S Pine St
Melbourne, FL
Cancer Care Centers Of Brevard Inc

2.
David Ross MD

240 N Wickham Rd
Melbourne, FL
Cancer Care Centers Of Brevard Inc

Providers in Cancer Care Centers Of Brevard Inc

1.Craig Badolato

1430 S Pine St
Melbourne Fl 32901-3119
Cancer Care Centers Of Brevard Inc
Hematology/oncology

2.Craig Badolato

240 N Wickham Rd
Melbourne Fl 32935-8663
Cancer Care Centers Of Brevard Inc
Hematology/oncology

3.Sumeet Chandra Md

2290 W Eau Gallie Blvd
Melbourne Fl 32935-3145
Cancer Care Centers Of Brevard Inc
Hematology/oncology

4.Rahul Chopra

240 N Wickham Rd
Melbourne Fl 32935-8663
Cancer Care Centers Of Brevard Inc
Radiation Oncology

5.Rahul Chopra

13050 Us Hwy 1
Sebastian Fl 32958-3733
Cancer Care Centers Of Brevard Inc
Radiation Oncology

6.Martin Dietrich

1430 S Pine St
Melbourne Fl 32901-3119
Cancer Care Centers Of Brevard Inc
Hematology/oncology

View all 18 members of Cancer Care Centers Of Brevard Inc medical group


Medicared For All
Vote!
Share